Comparison

BLU-945 European Partner

Item no. TMO-T9754-1mg
Manufacturer TargetMol
CASRN 2660250-10-0
Amount 1 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 200 mg 25 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,98
Smiles CO[C@@H]1CCN(C[C@@H]1F)c1nccc(Nc2cc3c(ccc(N4C[C@H](CS(C)(=O)=O)[C@H]4C)c3cn2)C(C)C)n1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias BLU945,BLU 945
Shipping Condition Cool pack
Available
Manufacturer - Targets
EGFR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
556.7
Description
BLU-945 is a reversible, potent, highly selective, and orally available epidermal growth factor receptor tyrosine kinase inhibitor (TKIs). BLU-945 inhibits EGFR phosphorylation in EGFR L858R/T790M/C797S and EGFR ex19del/T790M/C797S mutant cell lines. BLU-945 can be used in lung cancer research, including non-small cell lung cancer (NSCLC).
Pathways
JAK/STAT signaling|||Angiogenesis|||Tyrosine Kinase/Adaptors

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close